{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:39:17Z","timestamp":1792363157523,"version":"4.4.0"},"reference-count":208,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","gastrojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1053\/j.gastro.2016.02.031","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T05:15:32Z","timestamp":1462079732000},"page":"1393-1407.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2606,"title":["Bowel Disorders"],"prefix":"10.1053","volume":"150","author":[{"given":"Brian E.","family":"Lacy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferm\u00edn","family":"Mearin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Chey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Lembo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Simren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Spiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2016.02.031_bib1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2016.02.031_bib2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1572-0241.2007.01740.x","article-title":"Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior","volume":"103","author":"Ford","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1053\/j.gastro.2007.06.010","article-title":"Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study","volume":"133","author":"Halder","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib4","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1365-2036.2010.04464.x","article-title":"Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials","volume":"32","author":"Spiegel","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2016.02.031_bib5","first-page":"P405","article-title":"Abdominal pain versus abdominal discomfort: implications for diagnostic assessment of irritable bowel syndrome (IBS)","volume":"2","author":"Palsson","year":"2014","journal-title":"United Eur Gastroenterol J"},{"key":"10.1053\/j.gastro.2016.02.031_bib6","unstructured":"Whitehead WE, Palsson OS. Report on Rome Normative GI Symptom Survey.\u00a02014."},{"key":"10.1053\/j.gastro.2016.02.031_bib7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1365-2982.2012.01992.x","article-title":"Diagnostic criteria in IBS: useful or not?","volume":"24","author":"Mearin","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2016.02.031_bib8","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.cgh.2012.12.038","article-title":"A\u00a0positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome","volume":"11","author":"Begtrup","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2016.02.031_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10620-008-0694-z","article-title":"New clinical method for distinguishing D-IBS from other gastrointestinal conditions causing diarrhea: the LA\/IBS diagnostic strategy","volume":"55","author":"Pimentel","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2016.02.031_bib10","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/ajg.2014.181","article-title":"Episodic nature of symptoms in irritable bowel syndrome","volume":"109","author":"Palsson","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib11","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to intestinal transit time","volume":"32","author":"Lewis","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2036.2011.04948.x","article-title":"Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification","volume":"35","author":"Engsbro","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2016.02.031_bib13","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1365-2036.2004.02250.x","article-title":"Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications","volume":"20","author":"Vandvik","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2016.02.031_bib14","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1111\/j.1572-0241.2007.01540.x","article-title":"Comorbidity in irritable bowel syndrome","volume":"102","author":"Whitehead","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib15","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1111\/j.1572-0241.2008.01997.x","article-title":"Predictors of patient-assessed illness severity in irritable bowel syndrome","volume":"103","author":"Spiegel","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jpsychores.2013.05.008","article-title":"An international Delphi study to assess the need for multiaxial criteria in diagnosis and management of functional gastrointestinal disorders","volume":"75","author":"Austin","year":"2013","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1053\/j.gastro.2016.02.031_bib17","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2013.08.048","article-title":"Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care","volume":"145","author":"Ford","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib18","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.300.15.1793","article-title":"Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms?","volume":"300","author":"Ford","year":"2008","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2016.02.031_bib19","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3109\/00365521.2015.1007079","article-title":"Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey","volume":"50","author":"Patel","year":"2015","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl","key":"10.1053\/j.gastro.2016.02.031_bib20","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1016\/S0016-5085(14)60683-1","article-title":"Meta-analysis of the utility of common serum and fecal biomarkers in adults with IBS","volume":"146","author":"Menees","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17550","article-title":"Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation","volume":"17","author":"Waugh","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1053\/j.gastro.2016.02.031_bib22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11894-014-0391-3","article-title":"Tropical sprue in 2014: the new face of an old disease","volume":"16","author":"Ghoshal","year":"2014","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1053\/j.gastro.2016.02.031_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ibd.20059","article-title":"Symptomatic overlap between irritable bowel syndrome and microscopic colitis","volume":"13","author":"Limsui","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2016.02.031_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.13227","article-title":"Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea","volume":"42","author":"Slattery","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2016.02.031_bib25","doi-asserted-by":"crossref","first-page":"G775","DOI":"10.1152\/ajpgi.00155.2012","article-title":"Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome","volume":"303","author":"Camilleri","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1053\/j.gastro.2016.02.031_bib26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0016-5085(88)80017-9","article-title":"Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome","volume":"95","author":"Drossman","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0033-3182(96)71582-7","article-title":"Psychiatric disorder and outcome in irritable bowel syndrome","volume":"37","author":"Blewett","year":"1996","journal-title":"Psychosomatics"},{"key":"10.1053\/j.gastro.2016.02.031_bib28","doi-asserted-by":"crossref","first-page":"41S","DOI":"10.1016\/S0002-9343(99)00081-9","article-title":"Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome?","volume":"107","author":"Drossman","year":"1999","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2016.02.031_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","article-title":"The irritable bowel scoring system: a simple method of monitoring IBS and its progress","volume":"11","author":"Francis","year":"1997","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1053\/j.gastro.2016.02.031_bib30","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ajg.2010.480","article-title":"Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial","volume":"106","author":"Johannesson","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2016.02.031_bib31","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/ajg.2014.187","article-title":"American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation","volume":"109","author":"Ford","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib32","doi-asserted-by":"crossref","first-page":"b3154","DOI":"10.1136\/bmj.b3154","article-title":"Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial","volume":"339","author":"Bijkerk","year":"2009","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2016.02.031_bib33","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/ajg.2010.487","article-title":"Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial","volume":"106","author":"Biesiekierski","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib34","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.gastro.2013.01.049","article-title":"A\u00a0controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function","volume":"144","author":"Vazquez-Roque","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib35","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1038\/ctg.2015.21","article-title":"The effect of dietary intervention on irritable bowel syndrome: a systematic review","author":"Moayyedi","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.gastro.2013.09.046","article-title":"A\u00a0diet low in FODMAPs reduces symptoms of irritable bowel syndrome","volume":"146","author":"Halmos","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2013.04.051","article-title":"No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates","volume":"145","author":"Biesiekierski","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib38","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1053\/j.gastro.2015.07.054","article-title":"Diet low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial","volume":"149","author":"B\u00f6hn","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib39","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/ajg.2013.197","article-title":"Randomized clinical trial: macrogol\/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome","volume":"108","author":"Chapman","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib40","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1053\/j.gastro.2014.09.002","article-title":"American Gastroenterological Association Institute Technical Review on the pharmacological management of irritable bowel syndrome","volume":"147","author":"Chang","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib41","doi-asserted-by":"crossref","first-page":"C479","DOI":"10.1152\/ajpcell.00077.2014","article-title":"Differentiation between human ClC-2 and CFTR Cl- channels with pharmacological agents","volume":"307","author":"Cuppoletti","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1053\/j.gastro.2016.02.031_bib42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2036.2008.03881.x","article-title":"Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome\u2013results of two randomized, placebo-controlled studies","volume":"29","author":"Drossman","year":"2009","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1053\/j.gastro.2016.02.031_bib43","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2036.2011.04983.x","article-title":"Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation","volume":"35","author":"Chey","year":"2012","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1053\/j.gastro.2016.02.031_bib44","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/ajg.2012.255","article-title":"A\u00a012-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation","volume":"107","author":"Rao","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib45","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/ajg.2012.254","article-title":"Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety","volume":"107","author":"Chey","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/apt.12123","article-title":"Randomised clinical trials: linaclotide phase 3 studies in IBS-C\u2014a prespecified further analysis based on European Medicines Agency-specified endpoints","volume":"37","author":"Quigley","year":"2013","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1053\/j.gastro.2016.02.031_bib47","doi-asserted-by":"crossref","first-page":"S541","DOI":"10.14309\/00000434-201410002-01831","article-title":"Plecanatide, a novel uroguanylin analog: a 12-week, randomized, double-blind, placebo-controlled, dose-ranging trial to evaluate efficacy and safety in patients with irritable bowel syndrome with constipation (IBS-C)","author":"Miner","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib48","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1053\/j.gastro.2010.07.052","article-title":"Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis","volume":"139","author":"Rao","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/00365528709091003","article-title":"Loperamide in treatment of irritable bowel syndrome\u2014a double-blind placebo controlled study","volume":"130","author":"Lavo","year":"1987","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1053\/j.gastro.2016.02.031_bib50","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/00365529609006766","article-title":"A\u00a0double-blind placebo-controlled trial with loperamide in irritable bowel syndrome","volume":"31","author":"Efskind","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib51","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.cgh.2012.05.006","article-title":"Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea","volume":"10","author":"Wong","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2016.02.031_bib52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/gutjnl-2013-305965","article-title":"Increased colonic bile acid exposure: a relevant risk factor for symptoms and treatment in IBS","volume":"64","author":"Bajor","year":"2015","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2016.02.031_bib53","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/MCG.0b013e3182a88357","article-title":"Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis","volume":"48","author":"Khanna","year":"2014","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib54","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11894-007-0048-6","article-title":"The role of probiotics in management of irritable bowel syndrome","volume":"9","author":"Borowiec","year":"2007","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1053\/j.gastro.2016.02.031_bib55","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2004.11.050","article-title":"Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles","volume":"128","author":"O\u2019Mahony","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib56","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1572-0241.2006.00734.x","article-title":"Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome","volume":"101","author":"Whorwell","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib57","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/ajg.2014.202","article-title":"Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis","volume":"109","author":"Ford","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation","volume":"364","author":"Pimentel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2016.02.031_bib59","first-page":"109","article-title":"Efficacy and safety of repeat treatment with rifaximin for diarrhea-predominant irritable bowel syndrome (IBS-D): results of the TARGET 3 study","author":"Lembo","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib60","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/ajg.2010.25","article-title":"Ischemic colitis and complications of constipation associated with the use of alosetron under a risk management plan: clinical characteristics, outcomes, and incidences","volume":"105","author":"Chang","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib61","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/gutjnl-2013-305989","article-title":"A\u00a0randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea","volume":"63","author":"Garsed","year":"2014","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2016.02.031_bib62","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1080\/00365520802240255","article-title":"A\u00a0randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome","volume":"43","author":"Matsueda","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib63","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1476-5381.2012.02068.x","article-title":"Modulation of gastrointestinal function by MuDelta, a mixed micro opioid receptor agonist\/ micro opioid receptor antagonist","volume":"167","author":"Wade","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1053\/j.gastro.2016.02.031_bib64","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa1505180","article-title":"Eluxadoline treatment for irritable bowel syndrome with diarrhea","volume":"374","author":"Lembo","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2016.02.031_bib65","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/ajg.2014.148","article-title":"Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis","volume":"109","author":"Ford","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib66","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1365-2036.2008.03633.x","article-title":"Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome","volume":"27","author":"Vahedi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2016.02.031_bib67","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10787-997-0024-7","article-title":"Management of diarrhoeic type of irritable bowel syndrome with exclusion diet and disodium cromoglycate","volume":"5","author":"Leri","year":"1997","journal-title":"Inflammopharmacology"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2016.02.031_bib68","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/S0016-5085(14)60444-3","article-title":"A\u00a0multi-centre, parallel group, randomised placebo controlled trial of mesalazine for treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D)","volume":"146","author":"Lam","year":"2014","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2016.02.031_bib69","first-page":"S124","article-title":"Randomized placebo controlled multicenter trial of mesalazine in patients with irritable bowel syndrome (IBS)","volume":"146","author":"Barbara","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib70","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ajg.2012.66","article-title":"Acupuncture for rritable bowel syndrome: systematic review and meta-analysis","volume":"107","author":"Manheimer","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib71","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/oxfordjournals.aje.a116483","article-title":"Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders","volume":"136","author":"Talley","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.gastro.2016.02.031_bib72","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1365-2036.2007.03540.x","article-title":"Cumulative incidence of chronic constipation: a population-based study 1988\u22122003","volume":"26","author":"Choung","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2016.02.031_bib73","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/ajg.2011.164","article-title":"Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis","volume":"106","author":"Suares","year":"2011","journal-title":"Am J Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib74","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-2982.2007.00974.x","article-title":"Risk factors for chronic constipation and a possible role of analgesics","volume":"19","author":"Chang","year":"2007","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2016.02.031_bib75","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/j.1572-0241.2003.07591.x","article-title":"Association between physical activity, fiber intake, and other lifestyle variables and constipation in a study of women","volume":"98","author":"Dukas","year":"2003","journal-title":"Am J Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib76","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2036.2006.03238.x","article-title":"Chronic constipation: a survey of the patient perspective","volume":"25","author":"Johanson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2016.02.031_bib77","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.gastro.2012.10.028","article-title":"American Gastroenterological Association technical review on constipation","volume":"144","author":"Bharucha","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib78","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cgh.2010.06.031","article-title":"Digital rectal examination is a useful tool for identifying patients with dyssynergia","volume":"8","author":"Tantiphlachiva","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2016.02.031_bib79","doi-asserted-by":"crossref","first-page":"S366","DOI":"10.1016\/S0016-5085(13)61347-5","article-title":"Dyssynergic defecation can be diagnosed by questionnaire and physical examination","volume":"144","author":"Chiarioni","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib80","first-page":"385","article-title":"Measurement of colonic transit time: description and validation of a new method","volume":"10","author":"Chaussade","year":"1986","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1053\/j.gastro.2016.02.031_bib81","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0016-5085(87)90837-7","article-title":"Simplified assessment of segmental colonic transit","volume":"92","author":"Metcalf","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib82","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0016-5085(91)90466-X","article-title":"Scintigraphic measurement of regional gut transit in idiopathic constipation","volume":"101","author":"Stivland","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib83","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.gastro.2003.10.044","article-title":"Predictive value of the balloon expulsion test for excluding the diagnosis of pelvic floor dyssynergia in constipation","volume":"126","author":"Minguez","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib84","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/nmo.12096","article-title":"Diagnostic testing for dyssynergic defecation in chronic constipation: meta-analysis","volume":"25","author":"Videlock","year":"2013","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2016.02.031_bib85","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MPG.0b013e3181a0a595","article-title":"Familial clustering of habitual constipation: a prospective study in children from West Virginia","volume":"50","author":"Ostwani","year":"2010","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2016.02.031_bib86","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cgh.2006.10.009","article-title":"Influence of positive family history on clinical characteristics of functional constipation","volume":"5","author":"Chan","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2016.02.031_bib87","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1365-2982.2011.01772.x","article-title":"Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders","volume":"23","author":"Camilleri","year":"2011","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2016.02.031_bib88","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1053\/j.gastro.2014.02.054","article-title":"Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome","volume":"146","author":"Beyder","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib89","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4318\/tjg.2011.0238","article-title":"Normal defecation pattern, frequency of constipation and factors related to constipation in Turkish children 0-6 years old","volume":"22","author":"Kocaay","year":"2011","journal-title":"Turk J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib90","first-page":"431","article-title":"A\u00a0community-based study of the prevalence of constipation in young children and the role of dietary fibre","volume":"11","author":"Ip","year":"2005","journal-title":"Hong Kong Med J"},{"key":"10.1053\/j.gastro.2016.02.031_bib91","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/j.1365-2702.2010.03362.x","article-title":"Investigating factors associated with functional constipation of primary school children in Hong Kong","volume":"19","author":"Chan","year":"2010","journal-title":"J\u00a0Clin Nurs"},{"key":"10.1053\/j.gastro.2016.02.031_bib92","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.urology.2009.12.022","article-title":"An epidemiologic study of voiding and bowel habits in Korean children: a nationwide multicenter study","volume":"76","author":"Chung","year":"2010","journal-title":"Urology"},{"key":"10.1053\/j.gastro.2016.02.031_bib93","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/MPG.0b013e31817efbf7","article-title":"Bowel habits and toilet training in a diverse population of children","volume":"48","author":"Wald","year":"2009","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2016.02.031_bib94","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/sj.ejcn.1602573","article-title":"Association between dietary fiber, water and magnesium intake and functional constipation among young Japanese women","volume":"61","author":"Murakami","year":"2007","journal-title":"Eur J Clin Nutr"},{"key":"10.1053\/j.gastro.2016.02.031_bib95","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00394-002-0380-4","article-title":"Relationship between lifestyle factors and defecation in a Japanese population","volume":"41","author":"Nakaji","year":"2002","journal-title":"Eur J Nutr"},{"key":"10.1053\/j.gastro.2016.02.031_bib96","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1055\/s-2008-1038600","article-title":"The effects of exercise upon symptoms and quality of life in patients diagnosed with irritable bowel syndrome: a randomised controlled trial","volume":"29","author":"Daley","year":"2008","journal-title":"Int J Sports Med"},{"key":"10.1053\/j.gastro.2016.02.031_bib97","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00001610-199807000-00002","article-title":"Increasing oral fluids in chronic constipation in children","volume":"21","author":"Young","year":"1998","journal-title":"Gastroenterol Nurs"},{"key":"10.1053\/j.gastro.2016.02.031_bib98","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2982.2009.01442.x","article-title":"Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort","volume":"22","author":"Manabe","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2016.02.031_bib99","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cgh.2009.01.017","article-title":"Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation","volume":"7","author":"Rao","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2016.02.031_bib100","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1572-0241.1999.922_a.x","article-title":"Physiology of refractory chronic constipation","volume":"94","author":"Mertz","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib101","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/gutjnl-2011-301181","article-title":"Regional colon transit in patients with dys-synergic defaecation or slow transit in patients with constipation","volume":"61","author":"Nullens","year":"2012","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2016.02.031_bib102","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1111\/j.1365-2982.2010.01597.x","article-title":"Pancolonic spatiotemporal mapping reveals regional deficiencies in, and disorganization of colonic propagating pressure waves in severe constipation","volume":"22","author":"Dinning","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2016.02.031_bib103","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1053\/j.gastro.2013.07.014","article-title":"Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin","volume":"145","author":"Shekhar","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib104","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1365-2168.1999.00994.x","article-title":"Sensory and autonomic neuropathy in patients with idiopathic slow-transit constipation","volume":"86","author":"Knowles","year":"1999","journal-title":"Br J Surg"},{"key":"10.1053\/j.gastro.2016.02.031_bib105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0016-5085(85)80128-1","article-title":"Severe idiopathic constipation is associated with a distinctive abnormality of the colonic myenteric plexus","volume":"88","author":"Krishnamurthy","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib106","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/00042737-199612000-00014","article-title":"Decreased substance P levels in rectal biopsies from patients with slow transit constipation","volume":"8","author":"Tzavella","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2016.02.031_bib107","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1007\/BF02063253","article-title":"Nitric oxide synthase and VIP distribution in enteric nervous system in idiopathic chronic constipation","volume":"40","author":"Cortesini","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2016.02.031_bib108","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/003655299750025110","article-title":"Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation","volume":"34","author":"El-Salhy","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib109","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1152\/physrev.00037.2013","article-title":"Interstitial cells: regulators of smooth muscle function","volume":"94","author":"Sanders","year":"2014","journal-title":"Physiol Rev"},{"key":"10.1053\/j.gastro.2016.02.031_bib110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0016-5085(00)70409-4","article-title":"Decreased interstitial cell of cajal volume in patients with slow-transit constipation","volume":"118","author":"He","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib111","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/gut.51.4.496","article-title":"Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation","volume":"51","author":"Lyford","year":"2002","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2016.02.031_bib112","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/0016-5085(89)91500-X","article-title":"Psychological and physiological characteristics of patients with severe idiopathic constipation","volume":"97","author":"Wald","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib113","first-page":"26","article-title":"An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation","volume":"91","author":"Ashraf","year":"1996","journal-title":"Am J Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib114","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1348\/135910703770238266","article-title":"Abnormal illness behaviour and locus of control in patients with functional bowel disorders","volume":"8","author":"Hobbis","year":"2003","journal-title":"Br J Health Psychol"},{"key":"10.1053\/j.gastro.2016.02.031_bib115","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/BF01536418","article-title":"Behavioral modification of colonic function. Can constipation be learned?","volume":"35","author":"Klauser","year":"1990","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2016.02.031_bib116","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/ajg.2014.195","article-title":"The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis","volume":"109","author":"Moayyedi","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib117","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ajg.2013.62","article-title":"The role of food in the functional gastrointestinal disorders: introduction to a manuscript series","volume":"108","author":"Chey","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib118","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0002-9343(90)90177-F","article-title":"Cost-effective treatment of constipation in the elderly: a randomized double-blind comparison of sorbitol and lactulose","volume":"89","author":"Lederle","year":"1990","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2016.02.031_bib119","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/bmj.307.6907.769","article-title":"Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination","volume":"307","author":"Passmore","year":"1993","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2016.02.031_bib120","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1572-0241.2007.01199.x","article-title":"A\u00a0randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation","volume":"102","author":"Dipalma","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib121","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2036.2003.01390.x","article-title":"Comparison of efficacy and safety of two doses of two different polyethylene glycol-based laxatives in the treatment of constipation","volume":"17","author":"Chaussade","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2016.02.031_bib122","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/gut.44.2.226","article-title":"Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation","volume":"44","author":"Attar","year":"1999","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2016.02.031_bib123","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1136\/gut.2004.043620","article-title":"PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial","volume":"53","author":"Voskuijl","year":"2004","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2016.02.031_bib124","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/BF02234645","article-title":"Adverse effects of laxatives","volume":"44","author":"Xing","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"10.1053\/j.gastro.2016.02.031_bib125","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF01536053","article-title":"Effects of sennosides on colonic myoelectrical activity in man","volume":"34","author":"Frexinos","year":"1989","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2016.02.031_bib126","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1139\/y86-005","article-title":"Changes in colonic myoelectric spiking activity during stimulation by bisacodyl","volume":"64","author":"Schang","year":"1986","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1053\/j.gastro.2016.02.031_bib127","first-page":"G887","article-title":"The laxative effect of bisacodyl is attributable to decreased aquaporin-3 expression in the colon induced by increased PGE2 secretion from macrophages","volume":"301","author":"Ikarashi","year":"2011","journal-title":"Am J Physiol"},{"key":"10.1053\/j.gastro.2016.02.031_bib128","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cgh.2011.03.026","article-title":"Oral bisacodyl is effective and well-tolerated in patients with chronic constipation","volume":"9","author":"Kamm","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2016.02.031_bib129","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ajg.2010.41","article-title":"Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation","volume":"105","author":"Mueller-Lissner","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib130","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1365-2036.2007.03320.x","article-title":"Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety","volume":"25","author":"Johanson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2016.02.031_bib131","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s10620-009-1068-x","article-title":"Efficacy and safety of lubiprostone in patients with chronic constipation","volume":"55","author":"Barish","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2016.02.031_bib132","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1572-0241.2007.01524.x","article-title":"Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation","volume":"103","author":"Johanson","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib133","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJMoa1010863","article-title":"Two randomized trials of linaclotide for chronic constipation","volume":"365","author":"Lembo","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2016.02.031_bib134","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1016\/S0016-5085(13)60585-5","article-title":"Plecanatide, a novel guanylate cyclase-C (GC-C) receptor agonist, is efficacious and safe in patients with chronic idiopathic constipation (CIC): results from a 951 patient, 12 week, multi-center trial","volume":"144","author":"Miner","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2036.2011.04675.x","article-title":"Randomised clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation: a doubleblind study","volume":"34","author":"Simren","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2016.02.031_bib136","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/ajg.2011.285","article-title":"Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation","volume":"106","author":"Wong","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib137","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/ajg.2011.162","article-title":"A\u00a0randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation","volume":"106","author":"Chey","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib138","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0016-5085(98)70203-3","article-title":"5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine","volume":"115","author":"Grider","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib139","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1053\/gast.2001.21166","article-title":"Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder","volume":"120","author":"Bouras","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib140","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0016-5085(00)70251-4","article-title":"Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome","volume":"118","author":"Prather","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib141","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1542-3565(04)00356-8","article-title":"Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial","volume":"2","author":"Johanson","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2016.02.031_bib142","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1572-0241.2005.40749.x","article-title":"Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study","volume":"100","author":"Kamm","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib143","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/gut.2008.162404","article-title":"Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives","volume":"58","author":"Tack","year":"2009","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2016.02.031_bib144","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2036.2008.03884.x","article-title":"Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation\u2014a 12-week, randomized, double-blind, placebo-controlled study","volume":"29","author":"Quigley","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2016.02.031_bib145","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1365-2036.2011.04594.x","article-title":"Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation","volume":"33","author":"Attaluri","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2016.02.031_bib146","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/ajg.2010.305","article-title":"Efficacy of a Chinese herbal proprietary medicine (Hemp Seed Pill) for functional constipation","volume":"106","author":"Cheng","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib147","first-page":"69","article-title":"Systematic review of randomised controlled trials: probiotics for functional constipation","volume":"16","author":"Chmielewska","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib148","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ajg.2010.371","article-title":"The Incidence and gastrointestinal infectious risk of functional gastrointestinal disorders in a healthy US adult population","volume":"106","author":"Porter","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib149","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00384-006-0117-6","article-title":"Symptom patterns and relative distribution of functional bowel disorders in 1,023 gastroenterology patients in Iran","volume":"21","author":"Roshandel","year":"2006","journal-title":"Int J Colorectal Dis"},{"key":"10.1053\/j.gastro.2016.02.031_bib150","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000092887","article-title":"Frequency of functional bowel disorders among healthy volunteers in Mexico City","volume":"24","author":"Schmulson","year":"2006","journal-title":"Dig Dis"},{"key":"10.1053\/j.gastro.2016.02.031_bib151","doi-asserted-by":"crossref","first-page":"e43749","DOI":"10.1371\/journal.pone.0043749","article-title":"Epidemiology of functional diarrhea and comparison with diarrhea-predominant irritable bowel syndrome: a population-based survey in China","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2016.02.031_bib152","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4103\/1319-3767.65183","article-title":"Functional bowel disorders in Iranian population using Rome III criteria","volume":"16","author":"Sorouri","year":"2010","journal-title":"Saud J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib153","first-page":"594","article-title":"Prevalence of functional gastrointestinal disorders in Taiwan: questionnaire-based survey for adults based on the Rome III criteria","volume":"21","author":"Chang","year":"2012","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1053\/j.gastro.2016.02.031_bib154","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/bmj.300.6722.439","article-title":"Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate","volume":"300","author":"O'Donnell","year":"1990","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2016.02.031_bib155","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional\u00a0bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib156","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1111\/j.1572-0241.1999.01437.x","article-title":"Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome","volume":"94","author":"Vanner","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib157","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.amjmed.2011.11.006","article-title":"Review: Management of postprandial diarrhea syndrome","volume":"125","author":"Money","year":"2012","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2016.02.031_bib158","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2982.2012.01953.x","article-title":"Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea","volume":"24","author":"Gracie","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2016.02.031_bib159","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.gtc.2012.06.007","article-title":"Functional diarrhea","volume":"41","author":"Tack","year":"2012","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1053\/j.gastro.2016.02.031_bib160","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/0016-5085(91)90080-5","article-title":"Effect of eating on colonic motility and transit in patients with functional diarrhea. Simultaneous scintigraphic and manometric evaluations","volume":"101","author":"Bazzocchi","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib161","first-page":"297","article-title":"A\u00a0pilot study of motility and tone of the left colon in patients with diarrhea due to functional disorders and dysautonomia","volume":"92","author":"Choi","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib162","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/ajg.2012.102","article-title":"Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak","volume":"107","author":"Zanini","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib163","first-page":"1970","article-title":"Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study","volume":"98","author":"Parry","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib164","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/gut.24.3.236","article-title":"Psychological stress and the passage of a standard meal through the stomach and small intestine in man","volume":"24","author":"Cann","year":"1983","journal-title":"Gut"},{"issue":"Suppl","key":"10.1053\/j.gastro.2016.02.031_bib165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/00365528709091004","article-title":"Loperamide treatment of the irritable bowel syndrome","volume":"130","author":"Hovdenak","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib166","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/apt.13193","article-title":"Randomised clinical trial: colestyramine vs. hydroxypropyl cellulose in patients with functional chronic watery diarrhoea","volume":"41","author":"Fern\u00e1ndez-Ba\u00f1ares","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2016.02.031_bib167","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/gut.48.1.14","article-title":"Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome","volume":"48","author":"Serra","year":"2001","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2016.02.031_bib168","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/ajg.2013.198","article-title":"Bloating and distention in irritable bowel syndrome: the role of gas production and visceral sensation after lactose ingestion in a population with lactase deficiency","volume":"108","author":"Zhu","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib169","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1023\/A:1005554103531","article-title":"Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact","volume":"45","author":"Sandler","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2016.02.031_bib170","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1572-0241.2007.01755.x","article-title":"Abdominal bloating in employed adults: prevalence, risk factors, and association with other bowel disorders","volume":"103","author":"Tuteja","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib171","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/gut.2007.142810","article-title":"Prevalence and risk factors for abdominal bloating and visible distention: a population-based study","volume":"57","author":"Jiang","year":"2008","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2016.02.031_bib172","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/j.1572-0241.1999.01009.x","article-title":"Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome","volume":"94","author":"Lembo","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib173","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1111\/j.1572-0241.2001.05336.x","article-title":"Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome","volume":"96","author":"Chang","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib174","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cgh.2008.07.008","article-title":"Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome","volume":"7","author":"Ringel","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2016.02.031_bib175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00042737-199703000-00015","article-title":"Gender differences in irritable bowel symptoms","volume":"9","author":"Thompson","year":"1997","journal-title":"Euro J Gastroenterol & Hepatol"},{"key":"10.1053\/j.gastro.2016.02.031_bib176","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/j.1572-0241.2001.03961.x","article-title":"Gender-related differences in IBS symptoms","volume":"96","author":"Lee","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib177","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1365-2036.2011.04809.x","article-title":"Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome: the Systematic Investigation of Gastrointestinal Diseases in China (SILC)","volume":"34","author":"Zhao","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2016.02.031_bib178","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/gut.32.6.662","article-title":"Abdominal distension in female patients with irritable bowel syndrome: exploration of possible mechanisms","volume":"32","author":"Maxton","year":"1991","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2016.02.031_bib179","first-page":"241","article-title":"Abdominal distension in irritable bowel syndrome: the patient's perception","volume":"4","author":"Maxton","year":"1992","journal-title":"Eur Hepatol"},{"key":"10.1053\/j.gastro.2016.02.031_bib180","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/gut.48.2.216","article-title":"Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome","volume":"48","author":"Lewis","year":"2001","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2016.02.031_bib181","first-page":"112","article-title":"Small intestinal bacterial overgrowth: a comprehensive review","volume":"3","author":"Dukowicz","year":"2007","journal-title":"Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2016.02.031_bib182","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1053\/j.gastro.2009.01.067","article-title":"Abdominal distention results from caudo-ventral redistribution of contents","volume":"136","author":"Accarino","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib183","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1053\/j.gastro.2008.02.096","article-title":"Bloating and distention in irritable bowel syndrome: the role of visceral sensation","volume":"134","author":"Agrawal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib184","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/ajg.2009.251","article-title":"Bloating and distension in irritable bowel syndrome: the role of gastrointestinal transit","volume":"104","author":"Agrawal","year":"2009","journal-title":"Am J Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib185","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/j.1552-4604.1974.tb01382.x","article-title":"A\u00a0double-blind trial of simethicone in functional disease of the upper gastrointestinal tract","volume":"14","author":"Bernstein","year":"1974","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1053\/j.gastro.2016.02.031_bib186","first-page":"441","article-title":"Does Beano prevent gas? A double-blind crossover study of oral alpha-galactosidase to treat dietary oligosaccharide intolerance","volume":"39","author":"Ganiats","year":"1994","journal-title":"J\u00a0Fam Pract"},{"key":"10.1053\/j.gastro.2016.02.031_bib187","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/BF02936952","article-title":"Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial","volume":"32","author":"Liu","year":"1997","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib188","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.dld.2007.02.006","article-title":"Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial","volume":"39","author":"Cappello","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2016.02.031_bib189","doi-asserted-by":"crossref","first-page":"e0134349","DOI":"10.1371\/journal.pone.0134349","article-title":"Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial","volume":"10","author":"Lacy","year":"2015","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2016.02.031_bib190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0016-5085(03)00669-3","article-title":"Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders","volume":"125","author":"Drossman","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib191","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/gut.2005.077503","article-title":"A\u00a0controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome","volume":"55","author":"Tack","year":"2006","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2016.02.031_bib192","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1053\/gast.2002.33658","article-title":"Prokinetic effects in patients with intestinal gas retention","volume":"122","author":"Caldarella","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.02.031_bib193","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/j.1572-0241.2008.01866.x","article-title":"Intestinal gas and bloating: effect of prokinetic stimulation","volume":"103","author":"Accarino","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib194","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MCG.0000000000000246","article-title":"Definitions and outcome measures of clinical trials regarding opioid-induced constipation: a systematic review","volume":"49","author":"Gaertner","year":"2015","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib195","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain: systematic review of efficacy and safety","volume":"112","author":"Kalso","year":"2004","journal-title":"Pain"},{"key":"10.1053\/j.gastro.2016.02.031_bib196","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1191\/026921698674125048","article-title":"The relationship between opioid use and laxative use in terminally ill cancer patients","volume":"12","author":"Sykes","year":"1998","journal-title":"Palliat Med"},{"key":"10.1053\/j.gastro.2016.02.031_bib197","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ajg.2011.30","article-title":"Opioid-induced constipation: challenges and therapeutic opportunities","volume":"106","author":"Camilleri","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib198","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4637.2008.00495.x","article-title":"The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1)","volume":"10","author":"Bell","year":"2009","journal-title":"Pain Med"},{"key":"10.1053\/j.gastro.2016.02.031_bib199","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5055\/jom.2009.0015","article-title":"Opioid-induced bowel dysfunction in cancer-related\u00a0pain: causes, consequences, and a novel approach for its management","volume":"5","author":"Holzer","year":"2009","journal-title":"J\u00a0Opioid Manag"},{"key":"10.1053\/j.gastro.2016.02.031_bib200","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.gastro.2016.02.031_bib201","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1007\/s10620-010-1229-y","article-title":"Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation","volume":"55","author":"Sloots","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2016.02.031_bib202","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ajgsup.2014.8","article-title":"An evidence-based review of novel and emerging therapies for constipation in patients taking opioid analgesics","volume":"2","author":"Brenner","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.02.031_bib203","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0885-3924(01)00369-4","article-title":"Low-dose oral naloxone reverses opioid-induced constipation and analgesia","volume":"23","author":"Liu","year":"2002","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1053\/j.gastro.2016.02.031_bib204","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/026921639601000208","article-title":"An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer","volume":"10","author":"Sykes","year":"1996","journal-title":"Palliat Med"},{"key":"10.1053\/j.gastro.2016.02.031_bib205","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1056\/NEJMoa0707377","article-title":"Methylnaltrexone for opioid-induced constipation in advanced illness","volume":"358","author":"Thomas","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2016.02.031_bib206","unstructured":"FDA approves Relistor for opioid-induced constipation. 2014. Available at: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/2008\/ucm116885.htm. Accessed October 5, 2015."},{"key":"10.1053\/j.gastro.2016.02.031_bib207","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2982.2005.00640.x","article-title":"Alvimopan, a selective peripherally acting mu-opioid antagonist","volume":"17","author":"Camilleri","year":"2005","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2016.02.031_bib208","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1310246","article-title":"Naloxegol for opioid-induced constipation in patients with non-cancer pain","volume":"370","author":"Chey","year":"2014","journal-title":"N\u00a0Engl J Med"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508516002225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508516002225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T05:35:53Z","timestamp":1600493753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508516002225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":208,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0016508516002225"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2016.02.031","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726348638.793556882","asserted-by":"object"}]},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bowel Disorders","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2016.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The AGA Institute.","name":"copyright","label":"Copyright"}]}}